BioCentury

7:00 AM GMT, Mar 29, 2010
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Regulatory

Imatinib regulatory update

The U.K.'s NICE issued a preliminary appraisal for Glivec imatinib from Novartis for the adjuvant treatment of gastrointestinal stromal tumors (GISTs) after

Read the full 228 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.